Clinical trial
Evaluation of the Clinical Benefit of a Transmitter for Contralateral Routing of Signals (CROS)
NCT05106413 is registered in ClinicalTrials.gov with Sonova AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Clinical Benefit of a Transmitter for Contralateral Routing of Signals (CROS)
- Lead sponsor
- Sonova AG
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- October 26, 2021
- Completion date
- March 14, 2022
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.